Rapporter och faktablad

SwedenBIO undersöker regelbundet hur industrilandskapet inom life science ser ut. Vi mäter årligen branschens status i vår Life Science Barometer. Vart tredje år kartlägger vi de svenska läkemedelsprojekten i Pipelinerapporten. Vi ger även ut särskilda rapporter om utvalda områden som exempelvis finansiering, precisionsmedicin med mera.

The Life Science Barometer 2024

The Life Science Barometer 2024 offers a snapshot of the Swedish Life Science industry.

The 2024 report in high resolution PDF

The 2024 report in reduced size PDF

The Swedish Drug Discovery and Development Pipeline Report

The 2023 pipeline report shows that 159 Swedish R&D pharma and biotech companies are actively developing new drugs.

The homepage of the 2023 report

The 2023 report in PDF

The appendix of the 2023 report in PDF

Archive – Swedish Drug Discovery and Development Pipeline
2020 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

Branschstandard vid kapitalanskaffning inom life science

SwedenBIO:s rekommendation för informationsgivning avseende life science-bolag i utvecklingsfas.

Financing activities in the Life Sciences sector

A analysis of 361 financing events from 46 companies during the period 2007-2018.

Special focus on Rare Diseases

This paper, published together with Business Sweden, describes the orphan disease pipeline of Swedish companies and presents statistics over orphan drug designations granted by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Precision Medicine – the Swedish Industry Guide 2018

A first mapping of the Swedish precision medicine industry landscape. It is a guide to 76 companies, all of which are developing innovative products and services with the potential of advancing the field. At the end of the report, there is a listing of their relevant R&D projects as well as launched products.

Faktablad

I faktabladen finner du praktisk information och handfasta råd från andra medlemmar.

I samarbete med Kickfile/Devicia/Clarvin/Morris Law (januari 2021)

White paper – medical device software

I samarbete med Nasdaq (november 2020)

I samarbete med Valea (mars 2019)

I samarbete med Recall Capital (februari 2019)

Skapa hållbar handel på börsen – tips till små bolag

I samarbete med NDA Group (juni 2018)

Regulatoriska myndigheter bidrar till framgångsrik läkemedelsutveckling

I samarbete med Groth & Co (april 2018)

I samarbete med Paues Åberg Communications (mars 2018)

Medierelationer – hur du förbereder och hanterar en intervju